NCT00036036View on ClinicalTrials.gov

Study of CP-461 in Patients With Advanced Renal Cell Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 31, 2001

Study Completion Date

July 31, 2003

Conditions
Renal Cell Carcinoma
Interventions
DRUG

CP-461

Trial Locations (1)

90095

UCLA Medical Center, Los Angeles

Sponsors

Collaborators (1)

OSI Pharmaceuticals
All Listed Sponsors
collaborator

OSI Pharmaceuticals

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY